A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients

Lyme disease is the most common vector-borne disease in the United States, with an estimated incidence of 300,000 infections annually. Antibiotic intervention cures Lyme disease in the majority of cases; however, 10 to 20% of patients develop posttreatment Lyme disease syndrome (PTLDS), a debilitati...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrissette, Madeleine, Pitt, Norman, González, Antonio, Strandwitz, Philip, Caboni, Mariaelena, Rebman, Alison W., Knight, Rob, D’Onofrio, Anthony, Aucott, John N., Soloski, Mark J., Lewis, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527730/
https://www.ncbi.nlm.nih.gov/pubmed/32994327
http://dx.doi.org/10.1128/mBio.02310-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527730/
https://www.ncbi.nlm.nih.gov/pubmed/32994327
http://dx.doi.org/10.1128/mBio.02310-20

Ejemplares similares